CFTR Variant Class	Examples	CFTR Modulator Available?	Approved Drugs	Notes
Class I (no protein)	G542X, W1282X, R553X, 621+1G>T, 1717-1G>A, R1162X	No	None approved	~10% of CF patients; no CFTR protein for modulators to act on; experimental: readthrough agents, gene therapy, base editing
Class II (misfolding)	F508del, N1303K	Yes	ETI (Trikafta/Kaftrio), Orkambi, Symdeko, Alyftrek	~70% of alleles; correctors rescue misfolded protein to cell surface
Class III (gating)	G551D, S549N, R560T	Yes	Ivacaftor (Kalydeco), ETI, Alyftrek	Potentiators improve channel opening; highly responsive
Class IV (conductance)	R117H, R334W	Yes	Ivacaftor (Kalydeco), ETI	Reduced channel function; potentiators improve conductance
Class V (reduced quantity)	3849+10kbC>T, 2789+5G>A, A455E	Yes	ETI (Trikafta/Kaftrio), Alyftrek	Splicing variants producing reduced normal CFTR; milder phenotype
VVCC (varying consequence)	D1152H, D1270N, L997F, R74W, R75Q	No (not indicated for modulators)	None indicated	Do not meet CF diagnostic criteria; associated with CRMS/CFSPID or CFTR-RD
5T allele	IVS8-5T, TG12-5T, TG13-5T	No (not indicated for modulators)	None indicated	Splicing modifier; primarily associated with CBAVD and CFTR-RD, not CF
